Scarica l'app Stockscreener
24.28
1.18%
-0.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan
Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat
Adaptive Biotechnologies (ADPT) CEO sells 600K shares after exercising options - Stock Titan
Adaptive Biotechnologies (ADPT) director sells stock after option exercise - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) ex-officer plans new share sale - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at 26.16 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 1-Year HighHere's What Happened - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.16 USD - Investing.com
66,000 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Handelsbanken Fonder AB - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) director plans to resell 30,664 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) insider plans more sales after $7.96M already sold - Stock Titan
Adaptive Biotechnologies (ADPT) ex-officer plans cashless option share sale - Stock Titan
Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science - GeekWire
Adaptive Biotechnologies (NASDAQ: ADPT) insider plans multimillion stock sale - Stock Titan
Adaptive Biotechnologies (ADPT) plans multi-million-dollar stock sale for 2026 - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) lines up six-figure share sale for 2026 - Stock Titan
Dimensional Fund Advisors LP Cuts Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP - MarketBeat
Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales - simplywall.st
Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 3,000 Shares of Stock - MarketBeat
Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 3,000 shares under plan - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating the Growth Path with a 21.5% Revenue Surge - DirectorsTalk Interviews
Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 12-Month HighHere's Why - MarketBeat
ADPT (ADPT) insider outlines Form 144 sale of 3,000 shares - stocktitan.net
Adaptive Biotechnologies stock hits 52-week high at 25.04 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at 25.04 USD - Investing.com
Renaissance Technologies LLC Acquires Shares of 239,800 Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Corp (ADPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adaptive Biotechnologies Corp (ADPT) Stock News Today - TradingKey
Adaptive Biotechnologies Corp (1HM) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (1HM) Q4 2024 Earnings ReportResults, Call & Slides - tipranks.com
Adaptive Biotechnologies Corp (1HM) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Adaptive Biotechnologies Corp (ADPT) Shares Fall 4.1% -- GF Value Says Still Overvalued - GuruFocus
Adaptive Biotechnologies Corp Q2 2026: Revenue $71.6M, EPS $(0.25) — 10-Q Summary - TradingView
Adaptive Biotechnologies (NASDAQ: ADPT) raises $345M in 2031 notes - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating Growth in the Diagnostics Sector - DirectorsTalk Interviews
Adaptive Biotechnologies CCO Susan Bobulsky sells $31,176 shares By Investing.com - Investing.com South Africa
Form 4 Adaptive Biotechnologies Corp For: 3 August By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CCO Susan Bobulsky sells $31,176 shares - Investing.com
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $31,176.00 in Stock - MarketBeat
1.39%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):